Home/Pipeline/Heart Failure Monitoring & Prediction

Heart Failure Monitoring & Prediction

Heart Failure Decompensation

Development/ValidationActive

Key Facts

Indication
Heart Failure Decompensation
Phase
Development/Validation
Status
Active
Company

About Cardiosense

Cardiosense is a Chicago-based, private digital health company founded in 2017, focusing on the early detection and management of cardiovascular disease. Its integrated platform centers on the CardioTag™, a medical-grade wearable sensor that captures seismocardiogram (SCG), photoplethysmogram (PPG), and electrocardiogram (ECG) signals. Proprietary deep learning algorithms analyze these signals to generate predictive digital biomarkers for conditions like heart failure. The company aims to shift cardiac care from reactive to proactive by identifying measurable changes in cardiovascular function before symptoms appear.

View full company profile

Therapeutic Areas